Skip to main content
Back to Bills
OntarioDid not become law (session ended)40th Parliament, 2nd Session

Bill 75 explained in plain English

Health Insurance Amendment Act (Celiac Disease Screening), 2013

Ontario legislature bill summary, status, timeline, sponsor, votes, and official sources.

At a glance

Jurisdiction
Ontario Legislature
Legislature / Parliament
Legislative Assembly of Ontario
Session
40th Parliament, 2nd Session
Bill number
Bill 75
Full title
Health Insurance Amendment Act (Celiac Disease Screening), 2013
Current status
Did not become law (session ended)
Latest event
Carried
Last updated
May 28, 2013
Sponsor

Official Legislative Assembly of Ontario snapshot for 40th Parliament, 2nd Session. Representative vote breakdowns appear when the Assembly publishes an Ayes and Nays page for the bill.

Chamber
Legislative Assembly of Ontario
Current Stage
Carried
Latest Activity
May 28, 2013
Sponsor
Plain-language explanation
In plain English (our explanation)

Our plain-language take, written for civic education.

Source: By PoliticalData.ca

AI-assisted, reviewed before publishing
Short Version

Bill 75, the Health Insurance Amendment Act (Celiac Disease Screening), 2013, amends the Health Insurance Act to include celiac disease screening tests as an insured service under Ontario's health insurance plan.

What It Means

This bill amends the Health Insurance Act to make screening for celiac disease using specific tests an insured service in Ontario. This means these tests will be covered under the provincial health insurance plan.

What This Bill Does
  • Amends the Health Insurance Act.
  • Adds celiac disease screening, using the IgA-human tissue transglutaminase test or the endomysial antibody test, as an insured service under the Act.
  • Specifies that the Act comes into force on the day it receives Royal Assent.
Who Is Affected
  • Ontarians who may be screened for celiac disease.
  • Healthcare providers who administer celiac disease screening tests.
  • The Ontario health insurance plan.
Rights, Duties, Or Obligations
  • Celiac disease screening using the IgA-human tissue transglutaminase test or the endomysial antibody test is an insured service.
Important Dates
  • The Act comes into force on the day it receives Royal Assent.
Financial Or Tax Impacts
  • Specific celiac disease screening tests are now covered by the provincial health insurance plan, which may impact healthcare funding and patient costs for these tests.
Uncertainties Or Limits
  • The bill does not specify which healthcare professionals are authorized to order or administer these tests.
  • The bill does not detail the criteria or eligibility for receiving these screening tests.
  • The bill does not outline the process for claiming insured services related to these tests.
Laws Or Regulations Affected
Health Insurance Act
amends

Adds celiac disease screening tests (IgA-human tissue transglutaminase test or endomysial antibody test) as an insured service covered by the provincial health insurance plan.

Source: Section 11.2

Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.

Official text

Process Snapshot

Step 1
First reading
May 28, 2013
Step 2
Second reading
Not reached yet
Step 3
Committee review
Not reached yet
Step 4
Third reading
Not reached yet
Step 5
Royal assent
Not reached yet

Vote Summary

No published recorded division

This bill is still active. We only show vote counts after the legislature publishes a recorded division.

Sponsor
Bill Mauro
Sponsor party or district not listed
Jurisdiction
Ontario Legislature

No published representative vote breakdown

This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.

Official sources

Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.

How this data is sourced